GO:0004611 phosphoenolpyruvate carboxykinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004611 defines phosphoenolpyruvate carboxykinase (PEPCK) activity, the reversible decarboxylation of oxaloacetate to phosphoenolpyruvate and CO2.
• PEPCK exists as cytosolic (PCK1) and mitochondrial (PCK2) isoforms that differ in metabolic role and regulation.
• Beyond gluconeogenesis, PEPCK supports cataplerosis, glyceroneogenesis, amino acid metabolism, and redox balance.
• PEPCK is implicated in cancer metabolic reprogramming, ferroptosis resistance, adipocyte lipolysis, and macrophage immune function.
• PEPCK activity is regulated by transcription, allosteric effectors, phosphorylation, and acetylation.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of PEPCK function in disease.
Description
Phosphoenolpyruvate carboxykinase (PEPCK) is a carbon dioxide-fixing enzyme that catalyzes the reversible conversion of oxaloacetate to phosphoenolpyruvate, a committed step in gluconeogenesis and glyceroneogenesis. The Gene Ontology term GO:0004611 captures this catalytic activity, which is essential for maintaining glucose homeostasis and for cataplerotic flux from the tricarboxylic acid cycle. PEPCK exists in two isoforms: cytosolic PCK1 and mitochondrial PCK2, which differ in tissue distribution, regulation, and metabolic context. In recent years, PEPCK has emerged as a key node in cancer metabolism, immune cell function, and metabolic stress responses. For example, PCK2 supports glucose-deprived macrophage adaptation through partial gluconeogenesis, and its catalytic activity can counteract ferroptosis independently of mitochondrial stress. These findings highlight the need for precise, causal research tools to dissect PEPCK function in health and disease. This article provides a research-grade overview of GO:0004611, covering its definition, mechanism, key genes, regulation, disease relevance, and state-of-the-art methods including CRISPR-based models. All statements are grounded in peer-reviewed literature to support publication-ready research and generative-AI retrieval [1-8].
phosphoenolpyruvate carboxykinase activity At A Glance
| GO ID | GO:0004611 |
|---|---|
| GO term | phosphoenolpyruvate carboxykinase activity |
| Ontology | molecular_function |
| Synonym | PEP carboxykinase activity; PEPCK activity; phosphopyruvate carboxylase activity |
| Definition | Catalysis of the reaction: phosphate + oxaloacetate = phosphoenolpyruvate + CO2 + other reaction products. |
| Major function | Gluconeogenesis, glyceroneogenesis, cataplerosis, amino acid metabolism, redox balance |
| EC number | 4.1.1.32 (GTP-dependent) or 4.1.1.49 (ATP-dependent) |
| Cofactors | Divalent metal ions (e.g., Mn2+, Mg2+); GTP or ATP depending on isoform |
| Subcellular location | Cytosol (PCK1) and mitochondria (PCK2) |
What Is GO:0004611?
GO:0004611 phosphoenolpyruvate carboxykinase activity is defined as the catalysis of the reaction: phosphate + oxaloacetate = phosphoenolpyruvate + CO2 + other reaction products. In simpler terms, it is the enzyme activity that removes a carbon dioxide molecule from oxaloacetate while adding a phosphate group to form phosphoenolpyruvate, a high-energy intermediate used in gluconeogenesis and other metabolic pathways. This activity is reversible and can also carboxylate phosphoenolpyruvate to oxaloacetate, depending on cellular conditions.
Why Is phosphoenolpyruvate carboxykinase activity Important in Cell Biology?
GO:0004611 is critical because PEPCK activity sits at the intersection of glucose production, TCA cycle flux, and metabolic stress responses. Its dysregulation is linked to cancer, diabetes, and immune dysfunction, making it a high-value target for mechanistic studies and therapeutic development.
• Rate-limiting step in gluconeogenesis from lactate, amino acids, and TCA cycle intermediates.
• Supports glyceroneogenesis and lipid homeostasis in adipose tissue.
• Enables cataplerosis, preventing TCA cycle overload.
• Promotes cancer cell survival under glucose limitation.
• Counteracts ferroptosis via catalytic activity independent of mitochondrial stress.
• Modulates macrophage immune responses and collagen synthesis in senescence.
• Regulated by light in plants, indicating conserved regulatory mechanisms.
• Target for metabolic engineering and drug discovery.
Molecular Mechanism of phosphoenolpyruvate carboxykinase activity
Substrate binding and metal coordination
In simple terms: The enzyme grabs oxaloacetate and a metal ion to start the reaction.
PEPCK binds oxaloacetate and a divalent metal ion (Mn2+ or Mg2+) in its active site, positioning the substrate for decarboxylation. The metal ion stabilizes the enolate intermediate and facilitates phosphate transfer from GTP or ATP.
Decarboxylation and phosphoryl transfer
In simple terms: The enzyme removes CO2 and adds a phosphate group to form PEP.
The reaction proceeds via a ping-pong mechanism: oxaloacetate is decarboxylated to an enolate, which is then phosphorylated by GTP (PCK1) or ATP (PCK2) to yield phosphoenolpyruvate and GDP/ADP. This step is reversible and can drive carboxylation of PEP to oxaloacetate under gluconeogenic conditions.
Isoform-specific catalysis and regulation
In simple terms: Different versions of the enzyme work in different cell compartments.
Cytosolic PCK1 uses GTP and is regulated by transcription and acetylation, while mitochondrial PCK2 uses ATP and is less transcriptionally regulated. PCK2 catalytic activity can counteract ferroptosis independently of mitochondrial stress.
Allosteric and post-translational control
In simple terms: Other molecules can switch the enzyme on or off.
PEPCK activity is modulated by allosteric effectors such as acetyl-CoA and by phosphorylation; in maize, light-regulated phosphorylation controls its activity. Acetylation of PCK1 also affects its stability and function.
Key Genes Involved in GO:0004611 phosphoenolpyruvate carboxykinase activity
The following genes and proteins are central to phosphoenolpyruvate carboxykinase activity and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCK1 | Cytosolic PEPCK; gluconeogenesis and glyceroneogenesis | Metabolic disease, cancer, adipocyte biology |
| PCK2 | Mitochondrial PEPCK; cataplerosis and amino acid metabolism | Cancer, ferroptosis, macrophage adaptation |
| G6PC | Glucose-6-phosphatase; final step of gluconeogenesis | Gluconeogenesis regulation |
| FBP1 | Fructose-1,6-bisphosphatase; gluconeogenesis | Cancer metabolism |
| PKLR | Pyruvate kinase; glycolysis | Metabolic flux control |
| PC | Pyruvate carboxylase; oxaloacetate production | TCA cycle anaplerosis |
| MDH1 | Malate dehydrogenase; redox shuttle | Cytosolic NADH balance |
| MDH2 | Mitochondrial malate dehydrogenase | TCA cycle |
| SLC25A1 | Citrate transporter | Acetyl-CoA transport |
| ACACA | Acetyl-CoA carboxylase | Lipogenesis |
| PNPLA2 | Adipose triglyceride lipase | Lipolysis regulation by PCK2 |
| GPX4 | Glutathione peroxidase 4 | Ferroptosis defense |
| SLC7A11 | Cystine/glutamate antiporter | Ferroptosis and redox |
| NRF2 | Oxidative stress transcription factor | Antioxidant response |
| PPARGC1A | PGC-1alpha; mitochondrial biogenesis | Gluconeogenic gene regulation |
| CREB1 | cAMP response element-binding protein | PEPCK transcription |
| FOXO1 | Forkhead box O1 | Insulin signaling and gluconeogenesis |
How Is phosphoenolpyruvate carboxykinase activity Regulated?
PEPCK activity is regulated at multiple levels. Transcriptionally, PCK1 is induced by glucagon, glucocorticoids, and cAMP via CREB and FOXO1, and repressed by insulin. Post-translationally, acetylation and phosphorylation modulate PCK1 stability and activity. In plants, light-regulated phosphorylation of PEPCK controls its activity. Metabolically, PCK2 activity is influenced by mitochondrial energy status and can be uncoupled from mitochondrial stress in ferroptosis suppression.
phosphoenolpyruvate carboxykinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCK1 | Type 2 diabetes, obesity, cancer | KO mouse, overexpression in adipocytes |
| PCK2 | Cancer, ferroptosis resistance | KO cancer cell lines, point mutants |
| PCK1 | Senescence-associated inflammation | Macrophage KO, overexpression |
| PCK2 | Adipocyte lipolysis | Adipocyte-specific KO, knock-in |
| PCK1/PCK2 | Gluconeogenesis disorders | Liver-specific KO, tagged knock-in |
Cancer metabolism
PEPCK supports cancer cell survival under glucose limitation by enabling gluconeogenesis and cataplerosis. PCK2 expression is upregulated in some cancers and correlates with poor prognosis. Targeting PEPCK activity may disrupt metabolic flexibility in tumors.
Ferroptosis and oxidative stress
Mitochondrial PCK2 counteracts ferroptosis via its catalytic activity, independent of mitochondrial stress, suggesting a role in redox defense. This links PEPCK to cell death pathways and potential cancer therapy resistance.
Metabolic and inflammatory disorders
PCK1 is implicated in obesity and type 2 diabetes through its role in glyceroneogenesis and lipid metabolism. In senescent macrophages, polynucleotides enhance collagen synthesis via PCK1 modulation, linking PEPCK to tissue remodeling and inflammation.
Adipocyte lipolysis
PCK2 attenuates adipocyte lipolysis by repressing PNPLA2 activity, highlighting its role in lipid storage and mobilization. Dysregulation may contribute to lipodystrophies and metabolic syndrome.
From phosphoenolpyruvate carboxykinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PCK1 loss affect gluconeogenesis? | Liver-specific PCK1 knockout mouse |
| Does PCK2 catalytic activity suppress ferroptosis? | PCK2 knockout cancer cells + point mutant rescue |
| How does PCK2 regulate lipolysis? | Adipocyte PCK2 knockout and overexpression |
| Is PCK1 involved in macrophage collagen synthesis? | PCK1 knockout macrophages |
| What is the role of PCK2 in glucose-deprived macrophages? | PCK2 knockout macrophages + metabolomics |
| How is PEPCK activity regulated by phosphorylation? | Phospho-mutant knock-in cell lines |
How to Study the phosphoenolpyruvate carboxykinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | PEPCK catalytic activity | Kinetic studies, inhibitor screening |
| 13C metabolic flux | Gluconeogenic and cataplerotic flux | Cancer and immune cell metabolism |
| CRISPR knockout screen | Gene essentiality and synthetic lethality | Cancer dependency mapping |
| Western blot | Protein expression and modification | PCK1/PCK2 regulation |
| qRT-PCR | mRNA levels | Transcriptional regulation |
| Immunofluorescence | Subcellular localization | Mitochondrial vs cytosolic isoforms |
| Seahorse assay | Mitochondrial respiration | Metabolic phenotype |
| Lipolysis assay | Free glycerol release | Adipocyte function |
Enzymatic activity assays
PEPCK activity is measured spectrophotometrically by coupling oxaloacetate decarboxylation to NADH oxidation via malate dehydrogenase, or by monitoring PEP formation. Recombinant expression with chaperones can enhance activity for cestode PEPCK.
Metabolic flux analysis
Isotope tracing with 13C-labeled substrates quantifies PEPCK flux in gluconeogenesis and cataplerosis. This method reveals metabolic adaptations in glucose-deprived macrophages.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens identify genes that modulate PEPCK dependency in cancer and metabolic stress. Pooled screens with PEPCK inhibitors can uncover synthetic lethal interactions.
Proteomics and post-translational modification analysis
Mass spectrometry detects acetylation and phosphorylation of PCK1/PCK2, linking modifications to activity changes. Phosphoproteomics can reveal light-regulated phosphorylation in plants.
How CRISPR Can Be Used to Study GO:0004611 phosphoenolpyruvate carboxykinase activity
Knockout
CRISPR knockout of PCK1 or PCK2 eliminates PEPCK activity, enabling loss-of-function studies in gluconeogenesis, cancer metabolism, and ferroptosis. KO models reveal isoform-specific roles and compensatory mechanisms.
Point Mutation
Point mutations in catalytic residues (e.g., metal-binding or phosphate-transfer sites) dissect catalytic activity from non-catalytic functions. Such mutants can rescue ferroptosis resistance without restoring mitochondrial stress.
Knock-in
Knock-in of tagged PCK1/PCK2 (e.g., FLAG, GFP) allows affinity purification and live-cell imaging. Phospho-mutant knock-ins clarify regulation by phosphorylation.
Overexpression
Overexpression of PCK1 or PCK2 in cell lines boosts PEPCK activity, modeling cancer metabolic reprogramming and adipocyte lipolysis. Inducible systems control expression timing.
How EDITGENE Supports phosphoenolpyruvate carboxykinase activity Research
Researchers studying phosphoenolpyruvate carboxykinase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic or disease phenotypes. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for phosphoenolpyruvate carboxykinase activity research.
Frequently Asked Questions About phosphoenolpyruvate carboxykinase activity
What is phosphoenolpyruvate carboxykinase activity?
It is the enzyme activity defined by GO:0004611 that catalyzes the reversible conversion of oxaloacetate to phosphoenolpyruvate and CO2, a key step in gluconeogenesis.
What genes are involved in phosphoenolpyruvate carboxykinase activity?
The main genes are PCK1 (cytosolic) and PCK2 (mitochondrial), which encode the two PEPCK isoforms.
What is the difference between PCK1 and PCK2?
PCK1 is cytosolic and uses GTP, while PCK2 is mitochondrial and uses ATP; they differ in regulation and metabolic roles.
How is PEPCK activity regulated?
It is regulated by transcription (insulin, glucagon, cAMP), allosteric effectors, and post-translational modifications like phosphorylation and acetylation.
What diseases are linked to PEPCK?
PEPCK is implicated in cancer, type 2 diabetes, obesity, ferroptosis resistance, and inflammatory conditions.
How can I measure PEPCK activity?
Enzymatic assays coupling oxaloacetate decarboxylation to NADH oxidation, or isotope tracing, are commonly used.
Can CRISPR be used to study PEPCK?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect PEPCK function.
What is the role of PCK2 in ferroptosis?
PCK2 catalytic activity counteracts ferroptosis independently of mitochondrial stress, suggesting a redox-protective role.
Does PEPCK affect adipocyte lipolysis?
PCK2 attenuates adipocyte lipolysis by repressing PNPLA2 activity.
How does PEPCK contribute to cancer metabolism?
PEPCK supports gluconeogenesis and cataplerosis, enabling cancer cell survival under glucose limitation.
Conclusion
GO:0004611 phosphoenolpyruvate carboxykinase activity is a central metabolic enzyme activity with broad roles in gluconeogenesis, cataplerosis, redox balance, and disease. Its two isoforms, PCK1 and PCK2, are differentially regulated and contribute to cancer, metabolic disorders, and immune function [1-8]. CRISPR-based models are essential for causal dissection of PEPCK biology. EDITGENE offers comprehensive services to accelerate this research.
References
- 1. Yu S et al.. 2021. Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis.. Mol Metab 53:101257 PMID: 34020084
- 2. Wang Z et al.. 2019. Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase.. Trends Cancer 5(1):30-45 PMID: 30616754
- 3. Jiang C et al.. 2025. Phosphoenolpyruvate carboxykinase 2 (PCK2) attenuates bovine adipocyte lipolysis through PNPLA2 activity repression.. Funct Integr Genomics 25(1):157 PMID: 40679709
- 4. Cui H et al.. 2025. Mitochondrial phosphoenolpyruvate carboxykinase 2 counteracts ferroptosis via catalytic activity independent of mitochondrial stress.. Biochem Biophys Res Commun 778:152383 PMID: 40712389
- 5. Nongkhlaw J et al.. 2025. Delineation of Recombinant Cestode Phosphoenolpyruvate Carboxykinase Activity Co-expressed with Molecular Chaperones.. Protein J 44(4):425-436 PMID: 40643787
- 6. Byun KA et al.. 2025. Polynucleotides Enhance Collagen Synthesis via Modulating Phosphoenolpyruvate Carboxykinase 1 in Senescent Macrophages: Experimental Evidence.. Int J Mol Sci 26(17) PMID: 40943641
- 7. Chao Q et al.. 2014. Light-regulated phosphorylation of maize phosphoenolpyruvate carboxykinase plays a vital role in its activity.. Plant Mol Biol 85(1-2):95-105 PMID: 24435212
- 8. Schindlmaier K et al.. 2025. Metabolic adaptation of glucose-deprived macrophages involves partial gluconeogenesis.. Proc Natl Acad Sci U S A 122(44):e2419568122 PMID: 41160607
